BRIGHT GREEN

Project Scope

Bright Green Inc. is a bulk manufacturer of medical cannabis, dedicated to producing federally licensed, medical-grade cannabis for research, pharmaceutical applications, and international trade. To expand its operations, the company sought capital investment and strategic financial structuring to facilitate its growth.

Our Contribution

We partnered with Bright Green Inc. to develop a comprehensive financial strategy, guiding the company through its transition to a publicly traded entity. Our work included:

• Capital Structuring: Assisting in the initial capital raise and subsequent public offering to fund the development of 300 acres in New Mexico for cannabis cultivation.

• Public Listing: Facilitating Bright Green’s listing on an international exchange and securing a global broker to achieve cross-listing on the NASDAQ Exchange.

• Strategic Positioning: Aligning the company’s financial and operational structure to support long-term growth in the medical cannabis industry.

Through our collaboration, Bright Green Inc. became the first and largest publicly traded company in the U.S.federally authorized to cultivate, manufacture, and distribute medical cannabis, setting a new industry benchmark.